1[1]Dalwadi H,Krysan K,Heuze-Vourc,h N,et al.Cyclooxygena-2-dependent activation of signal transducer and activator transcription 3 by interleukin-6 in non-small cell lung cancer Clin Cancer Res,2005,11:7674-7682.
2[2]Pold M,Krysan K,Pold A,et al.Cyclooxygenase-2 modulat he insulin-like growth factor axis in non-small cell lung cancer.Clin Cancer Res,2004,64:6549-6555.
3[3]Lin MT,Lee RC,Yang PC,et al.Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human luadenocarcinoma CL1.0 cells.Involvement of phoshatidylinositol 3-kinase/Akt pathway.J Biol Chem,2001,276:48997-49002.
4[4]Shishodia S,Koul D,Aggarwal BB.Cyclooxygenase-inhibitor celecoxib abrogates TN F-induced NF-kappa B activation through inhibition of activation of I kappa B alphakinase and Akt in human non-small cell lung carcinoma:correlation with suppression of COX-2 synthesis.J Immunol,2004,173:2011-2022.
5[5]Hida T,Kozaki K,Muramatsu H,et al.Cyclooxygcnas-2 inhibitor induces apoptosis and enhances cytotoxicit y of various anticancer agents in non-small cell lung cancer cell lines.Clin Cancer Res,2000,6:2006-2011.
6[6]Krysan K,Reckamp KL,Dalwadi H,et al.Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.Cancer Res,2005,65:6275-6781.
7[7]Yuan A,Yu CJ,Shun CT,et al.Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor m RNA levels,tumor angiogenesis and prognosis in non-small cell lung cancer patients.Int J Cancer,2005,115:545-555.
8[8]Marrogi AJ,Travis WD,Welsh J A,et al.Nitric oxide synthase cyclooxygenase 2,and vascular endothelial growth factor in angiogenesis of non-small cell lung carcinoma.Clin Cancer Res,2000,6:4604-4606.
9[9]Claria J,Romano M.Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways.Impact inflammation and cancer.Curr Pharm Des,2005,11:3431-3442.
10[10]Sharma S,Yang SC,Zhu L,et al.Tumor cyclooxygenase-2 prostaglandin E-2dependent promotion of FOXP3 expression and CD4 + CD + T regulatory cell activities in tung cancer.Cancer Res,2005,65:5211-5220.
